Abiopharma

Cybin Announces $175 Million Registered Direct Offering

bioAffinity Technologies Announces Acceptance of Australian Patent Application for Platform to Detect and Characterize Multiple Lung Diseases

Revvity to Present at Upcoming Investor Conferences

BioNTech veranstaltet am 11. November 2025 „Innovation Series Day“ zu Forschung & Entwicklung

Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study

BioNTech to Host Innovation Series R&D Day on November 11, 2025

Accuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025

Alto Neuroscience to Participate in Upcoming Investor Conferences

Cronos Brings Back Popular, Limited-Edition Spinach® Green Apple-Flavored Products for the Fall Season

Context Therapeutics to Participate in Upcoming Investor Conferences